These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29976459)

  • 41. Editorial. BACE or beta-secretase -a target for drug discovery for treatment of Alzheimer's disease.
    Dunn BM
    Protein Pept Lett; 2008; 15(2):118. PubMed ID: 18289103
    [No Abstract]   [Full Text] [Related]  

  • 42. Evidence for dimeric BACE-mediated APP processing.
    Jin S; Agerman K; Kolmodin K; Gustafsson E; Dahlqvist C; Jureus A; Liu G; Fälting J; Berg S; Lundkvist J; Lendahl U
    Biochem Biophys Res Commun; 2010 Feb; 393(1):21-7. PubMed ID: 20097169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological and computational evaluation of resveratrol inhibitors against Alzheimer's disease.
    Koukoulitsa C; Villalonga-Barber C; Csonka R; Alexi X; Leonis G; Dellis D; Hamelink E; Belda O; Steele BR; Micha-Screttas M; Alexis MN; Papadopoulos MG; Mavromoustakos T
    J Enzyme Inhib Med Chem; 2016; 31(1):67-77. PubMed ID: 26147348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
    Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
    ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro antiamyloidogenic properties of 1,4-naphthoquinones.
    Bermejo-Bescós P; Martín-Aragón S; Jiménez-Aliaga KL; Ortega A; Molina MT; Buxaderas E; Orellana G; Csákÿ AG
    Biochem Biophys Res Commun; 2010 Sep; 400(1):169-74. PubMed ID: 20709023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
    Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
    Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
    Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.
    Zhao XJ; Gong DM; Jiang YR; Guo D; Zhu Y; Deng YC
    Eur J Med Chem; 2017 Sep; 138():738-747. PubMed ID: 28728106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tracking Alzheimer's.
    Roberts L
    US News World Rep; 1999 Nov; 127(17):73. PubMed ID: 10623301
    [No Abstract]   [Full Text] [Related]  

  • 50. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
    Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
    Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of Verubecestat, a BACE1 Inhibitor for the Treatment of Alzheimer's Disease.
    Thaisrivongs DA; Miller SP; Molinaro C; Chen Q; Song ZJ; Tan L; Chen L; Chen W; Lekhal A; Pulicare SK; Xu Y
    Org Lett; 2016 Nov; 18(22):5780-5783. PubMed ID: 27934506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.
    Choi SJ; Cho JH; Im I; Lee SD; Jang JY; Oh YM; Jung YK; Jeon ES; Kim YC
    Eur J Med Chem; 2010 Jun; 45(6):2578-90. PubMed ID: 20303626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease.
    Huang H; La DS; Cheng AC; Whittington DA; Patel VF; Chen K; Dineen TA; Epstein O; Graceffa R; Hickman D; Kiang YH; Louie S; Luo Y; Wahl RC; Wen PH; Wood S; Fremeau RT
    J Med Chem; 2012 Nov; 55(21):9156-69. PubMed ID: 22928914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors.
    Thompson LA; Shi J; Decicco CP; Tebben AJ; Olson RE; Boy KM; Guernon JM; Good AC; Liauw A; Zheng C; Copeland RA; Combs AP; Trainor GL; Camac DM; Muckelbauer JK; Lentz KA; Grace JE; Burton CR; Toyn JH; Barten DM; Marcinkeviciene J; Meredith JE; Albright CF; Macor JE
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6909-15. PubMed ID: 21974952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments.
    Bottegoni G; Veronesi M; Bisignano P; Kacker P; Favia AD; Cavalli A
    ChemMedChem; 2016 Jun; 11(12):1259-63. PubMed ID: 26663255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BACE1 inhibitors: a head group scan on a series of amides.
    Woltering TJ; Wostl W; Hilpert H; Rogers-Evans M; Pinard E; Mayweg A; Göbel M; Banner DW; Benz J; Travagli M; Pollastrini M; Marconi G; Gabellieri E; Guba W; Mauser H; Andreini M; Jacobsen H; Power E; Narquizian R
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4239-43. PubMed ID: 23735744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aryl sulfones: a new class of gamma-secretase inhibitors.
    Teall M; Oakley P; Harrison T; Shaw D; Kay E; Elliott J; Gerhard U; Castro JL; Shearman M; Ball RG; Tsou NN
    Bioorg Med Chem Lett; 2005 May; 15(10):2685-8. PubMed ID: 15863342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular docking and structure-activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors.
    Xu W; Chen G; Zhu W; Zuo Z
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6203-7. PubMed ID: 20850315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low anticoagulant heparin oligosaccharides as inhibitors of BACE-1, the Alzheimer's β-secretase.
    Zhang X; Zhao X; Lang Y; Li Q; Liu X; Cai C; Hao J; Li G; Yu G
    Carbohydr Polym; 2016 Oct; 151():51-59. PubMed ID: 27474542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Protease inhibitors].
    Hamada Y; Kiso Y
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1702-7. PubMed ID: 18051403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.